6
Dec
2018
Tag: oncology
3
Dec
2018
Bionest
Report on ESMO 2018 – Part One
We recently returned from the European Society for Medical Oncology (ESMO) meeting where conference news highlighted the increased movement of targeted therapies and immunotherapies into adjuvant and early-stage cancer settings, plus plenty of positive data from a variety of combination therapy trials in breast cancer, including triple-negative breast cancer. (Neo)Adjuvant Treatment Gets a Boost ...
4
Oct
2018
Bionest
Seminal Immuno-oncology Discoveries Honored by 2018 Nobel Prize
Seemingly spontaneous remissions from terminal cancers are known to occur on rare occasions. For over 100 years, this observation has spurred scientists to attempt to engage the immune system to fight cancer, with little success. But on October 1, the 2018 Nobel Prize in physiology and medicine was awarded to two scientists whose seminal discoveries...
23
Jul
2018
Bionest
Analysts’ Predictions on Top 10 Best Selling Drugs in 2024 — And Our Take
Market analyst firm Evaluate released their annual report, “EvaluatePharma World Preview 2018: Outlook to 2024,” last month. The report predicts that worldwide prescription drug sales will grow to over $1.2 trillion over the next six years. Novartis is projected to be 2024’s leading prescription drug company with $53.2 billion in overall sales, followed by Pfizer...
10
Jul
2018
Bionest
Precision Medicine and NGS Cancer Panels — ASCO Round-Up Part Two
As we wrote in our last post, precision medicine in oncology was the big theme of this year’s ASCO meeting. One of the key advances that has made possible this focus on treating cancer based on particular biomarkers expressed by a patient’s tumors, has been the advent of Next-Generation Sequencing (NGS)-based analysis of tumor DNA....
2
Jul
2018
Bionest
A Few Takeaways from ASCO 2018 — Part One
Precision medicine was an important theme of ASCO 2018 — the annual meeting of the American Society of Clinical Oncology — with this year’s meeting subtitled as “Delivering Discoveries, Expanding the Reach of Precision Medicine.” This theme was reflected not only in discussions around molecular profiling of patients, but also by the ever-increasing focus on...
21
May
2018
Bionest
Anticipating ASCO
We always greatly anticipate the scientific and educational sessions presented at the American Society of Clinical Oncology (ASCO) annual meeting, this year being held in Chicago from June 1-5. The meeting is the largest of its kind focused on cancer, attracting more than 30,000 oncology professionals from around the world to discuss ”state-of-the-art treatment modalities, new therapies,...
14
May
2018
Bionest
New Gains in Frontline Non-Small Cell Lung Cancer
Each spring, those of us who watch the oncology space turn our attention to two big U.S. meetings for the latest research news: the American Association of Cancer Research (AACR) annual scientific meeting, held in April, and the American Society of Clinical Oncology (ASCO), which will take place in June. AACR previously focused primarily on...
10
May
2018
Bionest
BIO2018, here we come: Real-time oncology and biomarkers for Alzheimer’s disease
The BIO International Convention is a huge gathering each year, as around 15-18,000 representatives from across industry and around the world get together to discuss policy, partnering, and product development over the course of four days. This year’s event, to be held in Boston from June 4 – 7, should be no exception. BIO has...
7
May
2018